Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Assets: 2024

Historic Return on Assets for Silence Therapeutics (SLN) over the last 1 years, with Dec 2024 value amounting to 0.28%.

  • Silence Therapeutics' Return on Assets was N/A to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year change of. This contributed to the annual value of 0.28% for FY2024, which is N/A change from last year.
  • Silence Therapeutics' Return on Assets amounted to 0.28% in FY2024.
  • In the past 5 years, Silence Therapeutics' Return on Assets ranged from a high of 0.28% in FY2024 and a low of 0.28% during FY2024.